rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sean McClain

Chief Executive Officer

Company insider

Files Form 4 as: Chief Executive Officer, Absci.

Every Form 4 they filed

In numbers

Trades disclosed
38
Buys
2
Sells
1
Bought
$59K
Sold
$160K
Companies
1
Companies where not an officer
0
First trade
26 Jul 2021
Last trade
12 Oct 2026
Last filed
14 Oct 2026

Companies traded

Where they are an officer
ABSI AbsciDirector, Officer, 10% owner · Life-science tools · last 12 Oct 20262 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Oct 2026filed 14 Oct 2026ABSI AbsciLife-science toolsSEC FORM 4 Code F$237K23,293 at $10.16filing
24 Jun 2026filed 26 Jun 2026ABSI AbsciLife-science toolsSEC FORM 4 Code F$603K59,896 at $10.08filing
24 Jun 2026filed 26 Jun 2026ABSI AbsciLife-science toolsSEC FORM 4 Code F$604K59,896 at $10.08filing
3 Mar 2026filed 16 Mar 2026ABSI AbsciLife-science toolsSEC FORM 4 Code F$71K25,316 at $2.80filing
3 Mar 2026filed 16 Mar 2026ABSI AbsciLife-science toolsSEC FORM 4 Code F$71K25,316 at $2.80filing
3 Mar 2026filed 4 Mar 2026ABSI AbsciLife-science toolsSEC FORM 4 Code F$71K25,316 at $2.80filing
3 Mar 2026filed 4 Mar 2026ABSI AbsciLife-science toolsSEC FORM 4 Code F$71K25,316 at $2.80filing
2 Mar 2026filed 16 Mar 2026ABSI AbsciLife-science toolsSEC FORM 4 Code A—406,200 at $0.00filing
2 Mar 2026filed 16 Mar 2026ABSI Abscioption or derivative · Life-science toolsSEC FORM 4 Code A—1,603,200 at $0.00filing
2 Mar 2026filed 16 Mar 2026ABSI Abscioption or derivative · Life-science toolsSEC FORM 4 Code A—1,603,200 at $0.00filing
2 Mar 2026filed 16 Mar 2026ABSI AbsciLife-science toolsSEC FORM 4 Code A—406,200 at $0.00filing
2 Mar 2026filed 4 Mar 2026ABSI AbsciLife-science toolsSEC FORM 4 Code A—406,200 at $0.00filing
2 Mar 2026filed 4 Mar 2026ABSI Abscioption or derivative · Life-science toolsSEC FORM 4 Code A—1,603,200 at $0.00filing
2 Mar 2026filed 4 Mar 2026ABSI Abscioption or derivative · Life-science toolsSEC FORM 4 Code A—1,603,200 at $0.00filing
2 Mar 2026filed 4 Mar 2026ABSI AbsciLife-science toolsSEC FORM 4 Code A—406,200 at $0.00filing
23 Feb 2026filed 25 Feb 2026ABSI AbsciLife-science toolsSEC FORM 4 Code M$480K396,399 at $1.21filing
23 Feb 2026filed 25 Feb 2026ABSI AbsciLife-science toolsSEC FORM 4 Code F$708K267,008 at $2.65filing
23 Feb 2026filed 25 Feb 2026ABSI Abscioption or derivative · Life-science toolsSEC FORM 4 Code M—396,399 at $0.00filing
23 Feb 2026filed 25 Feb 2026ABSI Abscioption or derivative · Life-science toolsSEC FORM 4 Code M—396,399 at $0.00filing
23 Feb 2026filed 25 Feb 2026ABSI AbsciLife-science toolsSEC FORM 4 Code M$480K396,399 at $1.21filing

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Todd BedrickSVP, CAO · SVP, CAO at Absci, filing Form 4 there in the last year
Zachariah JonassonCFO / Cbo · CFO / Cbo at Absci, filing Form 4 there in the last year
Ransi Mudalinayake SomaratneCMO, Head of R&D · CMO, Head of R&D at Absci, filing Form 4 there in the last year
Mary T. SzelaCEO and President · Director at Absci, filing Form 4 there in the last year
Karen K. McGinnisDirector · Director at Absci, filing Form 4 there in the last year